VRSK
66
21
EA
31
-3
EMN
56
-4
F
47
3
SIG
54
2
DIS
56
7
CI
66
7
GOOG
67
4
WFC
82
2
A
40
-4
ZTS
49
2
UA
59
3
REGN
53
-3
COST
53
-3
NRG
65
5
MCD
65
2
LYB
48
2
GIS
31
2
AVY
53
-8
NTRS
62
5
VRSK
66
21
EA
31
-3
EMN
56
-4
F
47
3
SIG
54
2
DIS
56
7
CI
66
7
GOOG
67
4
WFC
82
2
A
40
-4
ZTS
49
2
UA
59
3
REGN
53
-3
COST
53
-3
NRG
65
5
MCD
65
2
LYB
48
2
GIS
31
2
AVY
53
-8
NTRS
62
5
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Vs. Kymera Therapeutics Industry Stock Comparison

Sell
49

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
66.09
Seasonality Move:
12.17%
Buy
71

KYMR
Kymera Therapeutics

Last Price:
48.99
Seasonality Move:
65.72%
Sell
49
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $65.66. The Score for BIB is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

  • The ProShares Ultra Nasdaq Biotechnology share price today is $65.66
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 58.08 Buy
Chaikin Money Flow: 5146 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.88 - 66.3) Buy
Bollinger Bands (100): (59.2 - 66.5) Buy

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.85 Buy
20-day SMA: 63.41 Buy
50-day SMA: 64.39 Buy
200-day SMA: 59.54 Buy
8-day EMA: 63.65 Buy
20-day EMA: 63.59 Buy
50-day EMA: 63.77 Buy
200-day EMA: 59.89 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):